# ForQaly Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/forqaly-medical

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.forqaly.com
- Latest round: Series B (Sep 30, 2021)
- Investors on record: 9

## About

Based in Shanghai, China and founded in 2015, ForQaly Medical is a company focused on developing the percutaneous ventricular assistant device (pVAD). In September 2021, the company completed series B funding led by Legend Capital.

The company's product, SynFlow percutaneous ventricular assistant device, is comprised with catheter pump, external motor and console. And the product is indicated for cardiogenic shock. it can provide robust flow, and it is mini-invasive to patients. The intent of the SynFlow therapy is to reduce ventricular work and to provide the necessary circulatory support to allow heart rest.

## Funding rounds

- Series B, Sep 30, 2021 — Legend Capital, SAIF Partners, Lilly Asia Ventures, CD Capital, Co-Win Ventures, ChuangVest Ventures, Ningbo Kaitai Investment Partnership
- Series A, Apr 17, 2020 — Lilly Asia Ventures, Shanghai Zhangjiang Science & Technology Venture Capital, Apricot Capital

## Investors

- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series A, Series B
- Shanghai Zhangjiang Science & Technology Venture Capital — Series A
- Apricot Capital (https://capitalatlas.ai/funds/apricot-capital) — Series A
- Legend Capital — Series B
- SAIF Partners (https://capitalatlas.ai/funds/saif-partners) — Series B
- CD Capital — Series B
- Co-Win Ventures (https://capitalatlas.ai/funds/co-win-ventures) — Series B
- ChuangVest Ventures (https://capitalatlas.ai/funds/chuangvest-ventures) — Series B
- Ningbo Kaitai Investment Partnership — Series B